BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang T, Sun X, Li W, Hou G, Gao F. 1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship. Front Pharmacol 2021;12:661173. [PMID: 34177578 DOI: 10.3389/fphar.2021.661173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Maghraby MT, Salem OIA, Youssif BGM, Sheha MM. Design, synthesis, and modelling study of new 1,2,3-triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors. Chem Biol Drug Des 2023;101:749-59. [PMID: 36366966 DOI: 10.1111/cbdd.14178] [Reference Citation Analysis]
2 Murányi J, Duró C, Gurbi B, Móra I, Varga A, Németh K, Simon J, Csala M, Csámpai A. Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms. Int J Mol Sci 2023;24. [PMID: 36834866 DOI: 10.3390/ijms24043456] [Reference Citation Analysis]
3 Mohamed HA, Bekheit MS, Ewies EF, Awad HM, Betz R, Hosten EC, Abdel-wahab BF. Design of new hybrids indole/phthalimide/oxadiazole-1,2,3 triazole agents and their anticancer properties. Journal of Molecular Structure 2023;1274:134415. [DOI: 10.1016/j.molstruc.2022.134415] [Reference Citation Analysis]
4 Németh-Rieder A, Keglevich P, Hunyadi A, Latif AD, Zupkó I, Hazai L. Synthesis and In Vitro Anticancer Evaluation of Flavone-1,2,3-Triazole Hybrids. Molecules 2023;28. [PMID: 36677683 DOI: 10.3390/molecules28020626] [Reference Citation Analysis]
5 Zaher NH, Elhazek RM, Gouda AE, Khalil A, Elgazzar MG. Challenging breast cancer through novel sulfonamide-pyridine hybrids: design, synthesis, carbonic anhydrase IX inhibition and induction of apoptosis. Future Med Chem 2023;15:147-66. [PMID: 36762576 DOI: 10.4155/fmc-2022-0197] [Reference Citation Analysis]
6 Rao BV, Swain S, Siva B, Sasi Priya S, Jadav SS, Jain N, Ramalingam V, Suresh Babu K. Novel Heterocyclic Analogues of Bergenin as Anti-mitotic agents: Design, Synthesis, Biological Evaluation and Molecular Docking Study. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135048] [Reference Citation Analysis]
7 Mishra KN, Upadhyay HC. Coumarin-1,2,3-triazole hybrids as leading-edge anticancer agents. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.1072448] [Reference Citation Analysis]
8 Kaneti J, Kurteva V, Georgieva M, Krasteva N, Miloshev G, Tabakova N, Petkova Z, Bakalova SM. Small Heterocyclic Ligands as Anticancer Agents: QSAR with a Model G-Quadruplex. Molecules 2022;27:7577. [DOI: 10.3390/molecules27217577] [Reference Citation Analysis]
9 Lengerli D, Ibis K, Nural Y, Banoglu E. The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opin Drug Discov 2022;17:1209-36. [PMID: 36164263 DOI: 10.1080/17460441.2022.2129613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khan A, Naaz F, Basit R, Das D, Bisht P, Shaikh M, Lone BA, Pokharel YR, Ahmed QN, Parveen S, Ali I, Singh SK, Chashoo G, Shafi S. 1,2,3-Triazole Tethered Hybrid Capsaicinoids as Antiproliferative Agents Active against Lung Cancer Cells (A549). ACS Omega. [DOI: 10.1021/acsomega.2c03325] [Reference Citation Analysis]
11 Salinas-torres A, Portilla J, Rojas H, Becerra D, Castillo J. Synthesis, Spectroscopic Analysis, and In Vitro Anticancer Evaluation of 2-(Phenylsulfonyl)-2H-1,2,3-triazole. Molbank 2022;2022:M1387. [DOI: 10.3390/m1387] [Reference Citation Analysis]
12 Othman EM, Fayed EA, Husseiny EM, Abulkhair HS. Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates. Bioorganic Chemistry 2022;123:105762. [DOI: 10.1016/j.bioorg.2022.105762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
13 Li Y, Liang C. Cerium( III ) triflate–catalyzed cycloaddition reaction in aqueous conditions to substituted naphthotriazolediones. J Chinese Chemical Soc. [DOI: 10.1002/jccs.202200018] [Reference Citation Analysis]
14 Pan J, Ma L, Tang Y, Tian Y, Lin Y, Zhang L, Gao F, Lu G. Design, Synthesis and Biological evaluation of novel Quinazoline Derivatives as potential NF-κb inhibitors. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103908] [Reference Citation Analysis]
15 Saroha B, Kumar G, Kumar S, Kumari M, Rani M, Raghav N, Sahoo PK, Ghosh S, Mahata S, Nasare VD. Ultrasound assisted a one pot multicomponent and greener synthesis of 1,2,3-triazole incorporated aurone hybrids: Cathepsin B inhibition, anti-cancer activity against AGS cell line, and in-silico docking evaluation. Current Research in Green and Sustainable Chemistry 2022. [DOI: 10.1016/j.crgsc.2022.100295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Ihmaid SK, Aljuhani A, Alsehli M, Rezki N, Alawi A, Aldhafiri AJ, Salama SA, Ahmed HE, Aouad MR. Discovery of triaromatic flexible agents bearing 1,2,3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics. Journal of Molecular Structure 2022;1249:131568. [DOI: 10.1016/j.molstruc.2021.131568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Othman EM, Fayed EA, Husseiny EM, Abulkhair HS. Rationale design, synthesis, cytotoxicity evaluation, and in silico mechanistic studies of novel 1,2,3-triazoles with potential anticancer activity. New J Chem 2022;46:12206-16. [DOI: 10.1039/d2nj02061k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Zhang X, Zhang S, Zhao S, Wang X, Liu B, Xu H. Click Chemistry in Natural Product Modification. Front Chem 2021;9:774977. [PMID: 34869223 DOI: 10.3389/fchem.2021.774977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ye J, Mao L, Xie L, Zhang R, Liu Y, Peng L, Yang J, Li Q, Yuan M. Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:753676. [PMID: 34764872 DOI: 10.3389/fphar.2021.753676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sekh TV, Shyyka OY, Pokhodylo NT, Obushak MD. Synthesis of 1H-1,2,3-triazole-4-carbonitriles as building blocks for promising 2-(triazol-4-yl)-thieno[2,3-d]pyrimidine drug candidates. Synthetic Communications 2021;51:3175-3186. [DOI: 10.1080/00397911.2021.1966041] [Reference Citation Analysis]
21 Alam MM. 1,2,3-Triazole hybrids as anticancer agents: A review. Arch Pharm (Weinheim) 2022;355:e2100158. [PMID: 34559414 DOI: 10.1002/ardp.202100158] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]